SBB Research Group’s Merck MRK Stock Holding History

SBB Research Group’s Portfolio MRK Stock Details MRK Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q3	–	Sell	-2,379	Closed	-$217K	–	64
2022 Q2	$217K	Buy	+2,379	New	+$211K	0.09%	51

Other funds holding MRK

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return

Charles Schwab San Francisco, California $654B AUM 26.35% 1-Year Est. Return

Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

SBB Research Group's MRK Position: Q3 2022 in Review

SBB Research Group sold out of Merck (MRK) in Q3 2022, closing a stake of 2,379 shares — an estimated $217K sold.

SBB Research Group first reported a position in MRK in Q2 2022 and held it in 1 quarter. The position peaked at $217K in Q2 2022. 2,989 funds tracked by Wall St. Rank hold MRK as of Q3 2022.

SBB Research Group reported no remaining Merck position as of Q3 2022 after selling out during the quarter.
SBB Research Group sold 2,379 Merck shares in Q3 2022, an estimated $217K.
SBB Research Group first reported a position in Merck in Q2 2022 and held it in 1 quarter.
SBB Research Group's Merck position peaked at $217K in Q2 2022.
2,989 funds tracked by Wall St. Rank held Merck as of Q3 2022.

Based on SBB Research Group's 13F filing for Q3 2022, filed 9 Nov 2022.